Abstract:BACKGROUND & OBJECTIVE:In recent years, the neoadjuvant chemotherapy for cervical cancer has evoked more and more attention and has been used widely. But the chemosensitivity of individuals to various antitumor drugs is different. This study was to investigate the chemosensitivity of cervical cancer cells to antitumor drugs using in vitro MTT assay chemosensitivity test. METHODS:The sensitivity of fresh human cervical cancer cells from 32 patients to 9 cytotoxic drugs was tested using in vitro MTT assay. RESULTS:The cytotoxic activities of the 9 drugs for cervical cancer were in sequence from high to low as follows: liposomal paclitaxel, taxol, carboplatin (CBP), ifosfamide (IFO), etoposide (VP-16), 5-fluorouracil (5-FU), cisplatin (DDP), bleomycin (BLM), and cyclophosphamide (CTX). Generally, cervical cancer cells were more sensitive to paclitaxel, taxol, and CBP than to other drugs (P<0.05) with inhibition rates of 56.56%, 55.66%, and 46.81%, respectively. Stage Ib1 cervical cancer cells were more sensitive to taxol, paclitaxel, and CBP than to other drugs with inhibition rates of 58.71%, 53.00%, and 49.25%, respectively; stage Ib2 cervical cancer cells were more sensitive to paclitaxel and taxol than to other drugs with inhibition rates of 65.26% and 50.06%. Both moderately and poorly differentiated squamous cell cancer cells were more sensitive to taxol, paclitaxel, and CBP than to other drugs with inhibition rates of 52.01%, 49.21%, and 40.02% for the former, and 60.02%, 61.16%, and 48.75% for the latter. CONCLUSIONS:MTT assay, a sensitive and widely used chemosensitivity testing method, is helpful in sensitive drug screening and neoadjuvant chemotherapy regimen selection for cervical cancer. Cervical cancer cells are more sensitive to paclitaxel, taxol, and CBP than to other tested drugs in this study.

Analysis of Drug Sensitivity and Its Guidance in Clinic in 61 Cases of Breast Cancer Cell

Chemosensitivity in vitro of 25 anti-cancer drugs to primary cultured human breast cancer cells

Study of chemosensitivity for human breast cancer cells cultivated in primary generation in vitro

Influence of Neoadjuvant Chemotherapy on the Expression of Drug Resistance Genes in Breast Carcinoma

An Evaluation of the Sensitivity of Chemotherapeutical Agents to Breast Cancer by MTT Assay in Vitro

[Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].

Study on the sensitivity of primary tumor cells of patients with cervical cancer to chemotherapeutic combinations

Chemotherapy sensitivity and associated gene expression in human breast cancer cells

Sensitivity of different human colorectal tumor cell lines to commonly used chemotherapeutic drugs in vitro

Research and Exploratory of Chemotherapy Drugs Sensitivity Tests in Liver Cancer

Study on Chemosensitivity of Peripheral Blood Lymphocytes and Tumor Cells of Tumor Patients in Vitro

Study on susceptibility of eight common chemotherapy drug combinations in human cervical carcinoma cell in vitro

In Vitro Chemosensitivity Testing of Primary and Recurrent Breast Carcinomas and Its Clinical Significance

APOPTOSIS AND DRUG SENSITITY TEST OF LUNG CANCER CELL

Investigation On The Sensitivities Of Single And Combined Antitumor Drugs In Vitro By Real-Time Cell Electronic Sensing Technology

MTT measuring drug sensitivity of cancer cells and its relationship with clinical prescription

Study on Comparison of Chemosensitivity of Pirarubicin and Epirubicin in Breast Cancer by Means of CD-DST

Experimental Study on the Anti - Cancer Drugs' Sensitivity in the Colormetric Assay of Cancer Cells with MTT and Its Effective Factors

A Study on the Inhibition of Commonly-Used Anti-Cancer Drugs to Non-Small Cell Lung Carcinoma

STUDY OF CHEMOTHERAPY SENSITIVITY IN TUMOR CELL LINES ASSESSED BY APOPTOSIS

Detection of Chemosensitivity of Cervical Carcinoma in Vitro by MTT Assay and Its Clinical Significance